LAHORE: The Supreme Court of Pakistan was assured on Monday that compensation amount would be paid within six months to families of patients who died or were affected after consuming Efroze Chemicals’ medicine at Punjab Institute of Cardiology (PIC).

The Efroze Chemicals assured this before a three-judge bench headed by Chief Justice Tassaduq Hussain Jilani hearing a suo motu case against PIC spurious medicine scandal.  The company’s lawyer told the court that it would pay Rs400,000 per families of deceased patients, and Rs50,000 to affected patients. He added the process of paying compensation would start from January 15, 2014.

The court deferred the hearing for six months. Previously, the counsel for the company had told the court to give Rs300,000 each to heirs of the victims. The bench, however, rejected the proposal and directed the company to come up with a clear policy of payments to the families of deceased and effected patients.–STAFF REPORTER